» Articles » PMID: 37748505

Exploring Immune Modulatory Effects of Cyclotide-Enriched Viola Tricolor Preparations

Overview
Journal Planta Med
Specialty Biology
Date 2023 Sep 25
PMID 37748505
Authors
Affiliations
Soon will be listed here.
Abstract

is a medicinal plant with documented application as an anti-inflammatory herb. The standard of care for the treatment of inflammatory bowel disease is immunosuppressive therapeutics or biologics, which often have undesired effects. We explored herbal preparations that are rich in an emerging class of phytochemicals with drug-like properties, so-called cyclotides. As an alternative to existing inflammatory bowel disease medications, cyclotides have immunomodulatory properties, and their intrinsic stability allows for application in the gastrointestinal tract, for instance, via oral administration. We optimized the isolation procedure to improve the yield of cyclotides and compared the cellular effects of violet-derived organic solvent-extracts, aqueous preparations, and an isolated cyclotide from this plant on primary human T lymphocytes and macrophages, i.e., cells that are crucial for the initiation and progression of inflammatory bowel disease. The hot water herbal decoctions have a stronger immunosuppressive activity towards proliferation, interferon-, and interleukin-21 secretion of primary human T cells than a DCM/MeOH cyclotide-enriched extract, and the isolated cyclotide kalata S appears as one of the active components responsible for the observed effects. This effect was increased by a longer boiling duration. In contrast, the DCM/MeOH cyclotide-enriched extract was more effective in reducing the levels of cytokines interleukin-6, interleukin-12, interleukin-23, tumor necrosis factor-, and C - X-C motif chemokine ligand 10, secreted by human monocyte-derived macrophages. Defined cyclotide preparations of have promising pharmacological effects in modulating immune cell responses at the cytokine levels. This is important towards understanding the role of cyclotide-containing herbal drug preparations for future applications in immune disorders, such as inflammatory bowel disease.

Citing Articles

Advances in cyclotide research: bioactivity to cyclotide-based therapeutics.

Grover A, Singh S, Sindhu S, Lath A, Kumar S Mol Divers. 2025; .

PMID: 39862350 DOI: 10.1007/s11030-025-11113-w.


Plant-Derived Peptides: (Neglected) Natural Products for Drug Discovery.

Gruber C Planta Med. 2024; 90(7-08):627-630.

PMID: 38843800 PMC: 11156498. DOI: 10.1055/a-2219-9724.


Immunosuppressive Cyclotides: A Promising Approach for Treating Autoimmune Diseases.

Huynh N, Ho T, Pham Y, Dang L, Pham S, Dang T Protein J. 2024; 43(2):159-170.

PMID: 38485875 DOI: 10.1007/s10930-024-10188-y.

References
1.
Kashani A, Schwartz D . The Expanding Role of Anti-IL-12 and/or Anti-IL-23 Antibodies in the Treatment of Inflammatory Bowel Disease. Gastroenterol Hepatol (N Y). 2019; 15(5):255-265. PMC: 6589846. View

2.
Morphy R, Rankovic Z . Designed multiple ligands. An emerging drug discovery paradigm. J Med Chem. 2005; 48(21):6523-43. DOI: 10.1021/jm058225d. View

3.
Butterweck V, Nahrstedt A . What is the best strategy for preclinical testing of botanicals? A critical perspective. Planta Med. 2012; 78(8):747-54. DOI: 10.1055/s-0031-1298434. View

4.
Falanga C, Steinborn C, Muratspahic E, Zimmermann-Klemd A, Winker M, Krenn L . Ipecac root extracts and isolated circular peptides differentially suppress inflammatory immune response characterised by proliferation, activation and degranulation capacity of human lymphocytes in vitro. Biomed Pharmacother. 2022; 152:113120. PMC: 7614192. DOI: 10.1016/j.biopha.2022.113120. View

5.
Spolski R, Leonard W . Interleukin-21: a double-edged sword with therapeutic potential. Nat Rev Drug Discov. 2014; 13(5):379-95. DOI: 10.1038/nrd4296. View